Skip to content

A Comparative Clinaicl Study of Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion under Novel Expandable Working Channel and Minimally Invasive Transforaminal Lumbar Fusion

A Comparative Clinaicl Study of Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion under Novel Expandable Working Channel and Minimally Invasive Transforaminal Lumbar Fusion

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021889
Enrollment
Unknown
Registered
2019-03-15
Start date
2018-04-01
Completion date
Unknown
Last updated
2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar disc herniation, spondylolisthesis, and spinal stenosis

Interventions

Group 1:MIS-TLIF surgery
Group 2:PE-TLIF surgery

Sponsors

The Second Affiliated Xinqiao Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. aged 18 to 70 years; 2. typical clinical symptoms and signs; 3. concordant imaging evidence of single level lumbar spinal stenosis and/or lumbar disc herniation (LDH) and/or spondylolisthesis (limited to L3-4, L4-5, or L5-S1), such as computed tomography (CT) and magnetic resonance imaging (MRI); 4. conservative therapy for at least 3 months before surgery.

Exclusion criteria

Exclusion criteria: 1. serious underlying disease or mental illnesses; 2. combined with severe central stenosis, cauda equina syndrome, spinal instability, active infection, serious calcified fragments; 3. previous lumbar treatment with spinal surgery, ozone intervention or radiofrequency ablation; 4. unwilling or unable to participate in treatment and complete follow-up.

Design outcomes

Primary

MeasureTime frame
VAS of low back;VAS of leg;ODI;Macnab criteria;

Secondary

MeasureTime frame
Operation time;Creatine Kinase;C-reactive protein;Hematocrit;

Countries

China

Contacts

Public ContactShengxiang Ao

The Second Affiliated Xinqiao Hospital of Army Medical University

sanyida2008@sina.com+86 18523826996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026